-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VmYSdSETHKLar5Wezp3VXrflPzXpJaUcRZ/GaQi9JS0pDaSjKs5B+yR9hm6v65LX ovo6AvFPFRUcBFhrqjF7vQ== 0001104659-08-074995.txt : 20081205 0001104659-08-074995.hdr.sgml : 20081205 20081205150006 ACCESSION NUMBER: 0001104659-08-074995 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20081205 DATE AS OF CHANGE: 20081205 EFFECTIVENESS DATE: 20081205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-90514 FILM NUMBER: 081232548 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 S-8 POS 1 a08-29725_1s8pos.htm S-8 POS

 

As filed with the Securities and Exchange Commission on December 5, 2008

 

REGISTRATION NO. 333-90514

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

POST-EFFECTIVE AMENDMENT NO. 1 TO

 

FORM S-8

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

GENZYME CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

Massachusetts
(State or Other Jurisdiction of Incorporation)

 

06-1047163
(I.R.S. Employer Identification No.)


Genzyme Center, 500 Kendall Street, Cambridge, Massachusetts 02142
(Address of Principal Executive Offices)

 

GENZYME SURGICAL PRODUCTS CORPORATION

SAVINGS AND INVESTMENT PLAN

(Full Title of the Plan)

 

PETER WIRTH

Genzyme Corporation

Genzyme Center

500 Kendall Street

Cambridge, Massachusetts 02142

(617) 252-7500

(Name, Address and Telephone Number of Agent for Service)

 

with copies to:

PAUL KINSELLA

Ropes & Gray LLP

One International Place

Boston, Massachusetts 02110

(617) 951-7000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

x

Accelerated filer

o

Non-accelerated filer
(Do not check if a smaller reporting company)

o

Smaller reporting company

o

 

 

 


 

EXPLANATORY NOTE

 

Genzyme Corporation (“Genzyme”) filed a Registration Statement on Form S-8 (File No. 333-90514) with the Securities and Exchange Commission on June 14, 2002 (the “Registration Statement”), registering 25,000 shares of Genzyme common stock, $0.01 par value and an indeterminate amount of plan interests to be offered or sold pursuant to the Genzyme Surgical Products Corporation Savings and Investment Plan (the “Plan”).  Effective November 1, 2007, the Plan was merged into the Genzyme Corporation 401(k) Plan.  This Post-Effective Amendment No. 1 to the Registration Statement is being filed to deregister all plan interests and the 23,532.837 shares of Genzyme’s common stock that remain unsold under the Registration Statement.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on this 5th day of December 2008.

 

 

 

By:

  /s/ Peter Wirth

 

 

Peter Wirth

 

 

Executive Vice President, Legal and Corporate Development

 

Pursuant to the requirements of the Securities Act of 1933, the trustees (or other persons who administer the employee benefit plan) have duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on this 5th day of December 2008.

 

 

GENZYME SURGICAL PRODUCTS CORPORATION
SAVINGS AND INVESTMENT  PLAN

 

 

 

By:

Genzyme Benefit Plans Committee

 

 

 

 

 

 

By:

/s/ Zoltan Csimma

 

 

Zoltan Csimma

 

 

Senior Vice President, Chief Human Resources

 

 

Officer of Genzyme Corporation and Member of the

 

 

Genzyme Benefit Plans Committee

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----